Congenital chylothorax in a late preterm infant and successful treatment with octreotide

Ning Hui Foo, Yea Shwu Hwang, Chin Chuan Lin, Wen Hui Tsai

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


Chylothorax is defined as abnormal accumulation of lymphatic fluid in the pleural space and is a rare condition in neonates. Chylothorax causes respiratory and nutritional problems and a significant mortality rate. Octreotide is a long-acting somatostatin analog that can reduce lymphatic fluid production and has been used as a new strategy in the treatment of chylothorax. Here, we report a premature baby with severe bilateral pleural effusion diagnosed by prenatal ultrasound and subsequently confirmed to be congenital chylothorax after birth. This newborn baby was initially treated with bilateral chest tube insertion to relieve severe respiratory distress. However, the chylothorax recurred after a medium-chain-triglyceride-enriched formula was initiated. The accumulation of chylothorax diminished after the administration of octreotide. Therefore, octreotide may allow the patient to avoid invasive procedures, such as reinsertion of chest tubes or surgery.

Original languageEnglish
Pages (from-to)297-301
Number of pages5
JournalPediatrics and Neonatology
Issue number5
Publication statusPublished - 2011 Oct

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Congenital chylothorax in a late preterm infant and successful treatment with octreotide'. Together they form a unique fingerprint.

Cite this